News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva (TEVA) Must Clear Three Big Hurdles To Reclaim Its Perch



8/16/2017 5:55:29 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Teva Pharmaceutical Industries Ltd.'s (TEVA) ignominious slide from its perch as Israel's largest market cap company won't be reversed until the pharma company clears three big hurdles: installing a new CEO and management team, spinning off key units to reduce its debt and achieving clarity on how much competition it will face from generic versions of its branded multiple sclerosis drug Copaxone.

Bloomberg reported Tuesday that Teva lost its position as Israel's biggest firm due to depressed prospects for generics makers generally and disappointment over the company's second quarter earnings announcement on August 3.

Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES